🔗 Share this article

A shadow market for unlicensed weight-loss drugs is being driven by TikTok fitness influencers and vendors on communication apps, based on recent findings.

Experimental Drug Acquiring Popularity Via Social Media

Retatrutide, which remains in clinical trials, is being promoted by social media influencers for its supposed fat-burning properties. Viewers are urged to message these accounts directly for supplier links, while also receiving discount codes.

Thriving Trade on Messaging Platforms

Additionally, a robust trade exists on Telegram, where groups with thousands of members share “before and after” images, administration instructions and assertions of next-day UK delivery. Vendors market the substance there before redirecting buyers to other platforms for purchases.

Learning About Retatrutide

This medication is an experimental injectable developed by US drugmaker Eli Lilly. The drug targets three gut hormones – glucagon-like peptide-1, GIP and glucagon. Early trials indicate it could help individuals reduce up to a quarter of their total weight. Nicknamed the “triple G”, the substance is being hailed online as the next Ozempic.

Medical Professionals Voice Worries

However, doctors and pharmacists have cautions that the sale of what remains an unlicensed medication in the UK is worrisome and could result in users administering products of uncertain source.

Several professionals said the popularity for the experimental drug could be linked to the increasing price of licensed slimming products such as Mounjaro.

Regulatory Position and Implementation

Marketing the unapproved drug on social media or messaging apps is prohibited in the United Kingdom, as it is an unapproved drug that cannot be promoted or supplied for human use under the British medical regulations.

Some content creators attempt to sidestep the regulations by calling to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted substance, but advertising and supply can still violate medicines, marketing, and consumer regulations, potentially leading to fines, prosecution or imprisonment.

Platform Response and Content Elimination

Based on TikTok, the platform has removed violative material and banned associated hashtags and query recommendations. The company stated it was committed to maintaining the service safe and allocating resources in enhancing compliance measures.

Online Marketplace Activities

Research also discovered groups with up to nine thousand members marketing the experimental drug using Telegram's integrated search feature, which functions like a online catalog. Typing “retatrutide” instantly brings up groups with thousands of users, populated with photos of slimming results, positive testimonials and detailed instructions for preparing or administering at residence.

After minutes of joining one community, a seller shared contact information, where the majority of purchases take place. The seller provided an instruction manual and guaranteed delivery within two days. When asked whether the product was authentic, one seller responded: “You can’t be sure.” Another provided a photo of a alleged testing documentation. None asked about body mass, medical conditions or past usage.

Item Information and Costs

Within these groups, messages show black plastic parcels with Royal Mail labels, stating to contain new batches. One message read: “It took eight of us to load them this morning.”

Customers can select between powder vials, prepared at residence with purified liquid, or pre-filled injectors typically sold at £160 for 20 milligrams. When questioned how long a injector should be used, vendors give contradictory responses varying between a few weeks to “depends on your body”.

Service Moderation and Safety Actions

A spokesperson for Telegram stated it regularly moderated harmful material on its service including content that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Cautions

“Individuals are administering substances they cannot confirm. Even if the research behind retatrutide is valid, these digital versions may not contain what they advertise,” said a pharmacy expert, the director of pharmacy at Chemist4U.

A medical professional of Asda Online Doctor connected the increase in interest to recent cost increases for authorized slimming medications such as Mounjaro. “With prices rising, individuals are turning to social media. But counterfeit treatments are highly dangerous. You cannot know what’s contained or whether the environment they were produced in was sterile,” she said.

Her team has previously seen individuals harmed by personal administration from unverified suppliers. “We recognize the disappointment, but purchasing from messaging apps or communication platforms is gambling with your health,” stated Wyllie. “These materials could be contaminated or incorrectly dosed.”

Producer Statement

A spokesperson from Eli Lilly stated the substance was in phase 3 clinical trials and had not been reviewed or authorized by any regulatory agency globally. “Therefore at this time no one can market [it] for personal consumption,” they said, noting that any product “falsely representing itself as a Lilly experimental substance not yet approved … may expose patients to possibly serious medical dangers”.